WORLD VACCINE CONGRESS ASIA 2012 (June 11-14,2012, Singapore)

WORLD VACCINE CONGRESS ASIA 2012

11^th-14^th of June 2012 | Singapore

 

Subject: (ADV) Find out about and influence the future of the Asian Vaccines industry!

 

Vaccines are not only an effective strategy to solve major global health issues, they are also of central importance for the pharmaceutical and health industries.

 

Find out what role they play at World Vaccine Congress Asia

 

As in every market and industry Asia is predicted to become the key market in future. World Vaccine Congress Asia will be focusing on the key trends and developments in the region, bringing together key decision makers and leaders from pharmas, biotechs, research institutes, NGOs, governments and regulators.

Find out what focus areas will be covered and featured in the three main conferences:  

-       World Vaccine Partnering Congress Asia

-       World Vaccine Trials Congress Asia

-       World Vaccine Manufacturing Congress Asia

 

And the World Influenza Congress Asia Summit

 

Join us in Singapore from the 11^th-14^th of June 2012 to meet and network with global and Asian leaders, who like yourself are looking to further drive the growth and importance of vaccines in global health.

 

Find out more about opportunities available at this conference and contact me at
valerie.lim@terrapinn.com or +65 6322 2766!

 

Best regards,

Valerie Lim

Marketing Executive

 

TERRAPINN PTE LTD

1 Harbourfront Place, #18-01 Harbourfront Tower 1 Singapore 098633

( DID: +65 6322 2766 | ( FAX: +65 6226 3264 | : E-mail: valerie.lim@terrapinn.com

 

Terrapinn is a business media company. Our products are trade exhibitions, conferences, training solutions and electronic and print publications. Terrapinn owns a portfolio of B2B brands.  www.terrapinn.com

 

P.S.: We are still looking for senior level pharma representatives to showcase their expertise, network with the participating NGOs, Biotechs, CDCs and regulators and influence the industry trends over the coming years.